Evidence map›Paper›PMID 34097089›Full record

ReviewDer Nervenarzt2021

[Disease burden of borderline personality disorder: cost of illness, somatic comorbidity and mortality].

Frank Jacobi, Raphaela Grafiadeli, Hannah Volkmann, Isabella Schneider

Abstract readReview
PubMed Publisher
In one paragraph

Review in Der Nervenarzt, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 3 pooled it
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 3 syntheses or guidelines pooled it, 23 citations in OpenAlex.

  1. The Association Between Emotional Intelligence and Borderline Personality Disorder: A Meta-Analysis.International journal of psychology : Journal international de psychologie · 2025
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Observational
  6. Sleep disturbance and maladaptive sleep-related cognitions in borderline personality disorder in the longitudinal McLean Study of Adult Development.Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · 2025
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Frank JacobiKlinische Psychologie und Psychotherapie, Psychologische Hochschule Berlin (PHB), Am Köllnischen Park 2, 10179, Berlin, Deutschland. f.jacobi@phb.de.
Raphaela GrafiadeliKlinische Psychologie und Psychotherapie, Psychologische Hochschule Berlin (PHB), Am Köllnischen Park 2, 10179, Berlin, Deutschland.
Hannah VolkmannKlinische Psychologie und Psychotherapie, Psychologische Hochschule Berlin (PHB), Am Köllnischen Park 2, 10179, Berlin, Deutschland.
Isabella SchneiderKlinik für Allgemeine Psychiatrie, Universitätsklinikum Heidelberg, Zentrum für Psychosoziale Medizin, Heidelberg, Deutschland.
Psychologische Hochschule Berlin · DEHeidelberg University · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSevere mental illnesses (SMI) are characterized by high psychosocial impairment as well as by increased somatic morbidity and mortality. The term SMI commonly includes psychotic, bipolar and severe unipolar depressive disorders but borderline personality disorder (BPD) also shows severe sequelae of the disease. MATERIAL AND

methodsPublished reviews and studies since 2010 examining disease burden of BPD, in terms of direct and indirect costs of illness, somatic comorbidity, and mortality were included. Furthermore, administrative data (clinically recorded billing data in Germany), comorbidity and mortality from a comprehensive analysis (n > 59 million, age ≥ 18 years) are reported.

resultsInternational studies reveal an increased disease burden, comorbidity, and mortality for BPD. In Germany BPD (administrative 1‑year prevalence 0.34%) is associated with increased rates of somatic sequelae of trauma, hepatitis, HIV, COPD, asthma, and obesity. The estimated reduced life expectancy is 5.0-9.3 years of life lost (depending on age and sex). DISCUSSION: The burden of disease in BPD is clearly increased (cost of illness, somatic comorbidity and mortality). The increased mortality can mainly be explained by deaths as a consequence of poor physical health and associated BPD-related health behavior and only to a lesser degree by suicide. These results highlight the importance of classifying BPD as an SMI and the necessity to provide not only psychotherapeutic and psychiatric but also adequate somatic prevention and treatment. Individual improvement of everyday care as well as establishing new interdisciplinary and multiprofessional services could enhance health equality for people with BPD.

Indexed as

Borderline Personality DisorderCost of IllnessAdolescentComorbidityGermanyHumansPrevalenceBorderline personality disorderPhysical healthSevere mental disordersSomatic preventionSuicide

Identifiers

PMID34097089
OpenAlexW3172226795

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.